Tafinlar Prices, Coupons and Patient Assistance Programs
Tafinlar (dabrafenib) is a member of the multikinase inhibitors drug class and is commonly used for Melanoma - Metastatic, Non-Small Cell Lung Cancer and Thyroid Cancer.
Tafinlar Prices
The cost for Tafinlar oral capsule 50 mg is around $9,411 for a supply of 120 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Tafinlar is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Tafinlar availability.
This Tafinlar price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Oral Capsule
| Quantity | Per unit | Price |
|---|---|---|
| 120 | $78.43 | $9,411.27 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
| Quantity | Per unit | Price |
|---|---|---|
| 120 | $101.05 | $12,126.06 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tafinlar Coupons and Rebates
Tafinlar offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Tafinlar Novartis Universal Co-Pay Card: Eligible patients may pay no more than $25 for each of your prescriptions with a maximum savings of $15,000 per year; for additional information contact the program at 877-577-7756.
| Applies to: | Tafinlar |
| Number of uses: | per prescription per calendar year |
Tafinlar Novartis Universal Co-Pay Card: Eligible patients may pay no more than $25 for each of your prescriptions with a maximum savings of $15,000 per year; for additional information contact the program at 877-577-7756.
| Applies to: | Tafinlar |
| Number of uses: | per prescription per calendar year |
Patient Assistance Programs for Tafinlar
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)
Elligibility requirements:- Contact program for details.
- At or below 600% of FPL
- Not specified
- The patient must reside in the US, Puerto Rico or the USVI.
- For Focalin XR, Clozaril, and Ritalin LA, Clozarila pharmacy card will be issued. All other medication will be shipped directly to the patient, unless otherwise noted. *Additional products may be available. Please contact the program for a complete product listing. www.pap.novartis.com
Applicable drugs:
- Tafinlar (dabrafenib) Capsule
Provider: HealthWell Foundation Copay Program
Elligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Tafinlar (dabrafenib) Capsule
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Tafinlar (dabrafenib) Capsule
Provider: PANO (Novartis Patient Assistance Now Oncology)
Elligibility requirements:- Determined case by case
- Income Guidelines published on Program Website
- Not specified
- The patient must reside in the US, Puerto Rico or the USVI.
- Eligibility determined on a case-by-case basis. Eligible patients with private insurance may pay $25 per month and Novartis pays the remaining co-pay, up to $15,000 per calendar year, per product.
Applicable drugs:
- Tafinlar (dabrafenib) Capsule
More about Tafinlar (dabrafenib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- En Español
- 2 Reviews
- Drug class: multikinase inhibitors
- FDA Approval History
